The coronavirus disease 2019 (COVID-19) has caused a world pandemic, posing a huge threat to the health of the people, the national economy, and the stability of the world. 1,Reference Ma, Liu and Liu2 By establishing higher levels of herd immunity, widespread vaccination is the most effective way to control the pandemic of COVID-19. The vaccination of COVID-19 vaccine for adolescents aged 12-17 y in China has been started since July 2021. However, the effectiveness of the vaccine against COVID-19 gradually decreases, with the waning of immunity over time. Reference Barda, Dagan and Cohen3,Reference Tré-Hardy, Cupaiolo and Wilmet4 The third vaccine dose, referred to as a booster, is proved to be effective to overcome this issue, and studies have shown that the third dose of COVID-19 vaccine is safe and effective. Reference Hause, Baggs and Gee5
Numerous factors affect the acceptance of the third dose of COVID-19 vaccine during the pandemic, especially among adolescents. This study aimed to determine the attitude and intention factors for the third dose of COVID-19 vaccine. Understanding the willingness and attitudes of adolescents toward the third dose could help policy-makers identify appropriate interventions to alleviate worries and inform public health decisions about the COVID-19 vaccination.
Methods
Study Design
A cross-sectional questionnaire was developed and distributed among adolescents aged 12-17 y in 3 provinces (Anhui, Fujian, and Jiangsu) of the eastern region of China from August 16 to October 28, 2021, and 1 senior high school and 1 junior high school in each province were selected. The protocol was approved by the Ethics Committee of the Nanjing Drum Tower Hospital (#2021-462-01). The informed consent was indicated at the beginning of the questionnaire, which was consented by the parents or guardians of the participants.
Measures
The survey consisted of questions as follows: (1) demographic information; (2) knowledge of and attitude to COVID-19 vaccine; (3) willingness to accept the third dose. The detailed questions in English of our questionnaire are provided in Supplementary File 1 (Text S1).
Statistical Analysis
Descriptive analysis of the demographics was expressed by means and standard deviations or proportions. To compare the main variables between groups, independent t-tests were performed to analyze the continuous variables, and chi-squared tests were performed to analyze the categorical variables. Multivariable logistic regression analysis was performed, including all factors showing significance (P < 0.05) in the univariate analysis, to explore the factors associated with the willingness to accept the third dose of COVID-19 vaccine. All statistical analyses were performed using the R software (R version 4.04). A P value of ≤ 0.05 was considered statistically significant.
Results
Demographic Characteristics
The survey was released to 2100 adolescents, and a total of 2048 (97.5%) responded. Of them, 202 (9.8%) who did not complete survey questionnaire were excluded. Finally, 1847 participants who completed survey questionnaire were included in this study. There were 48.2% (834/1846) males and 60.9% (1110/1822) from rural areas. Overall, 94.3% (1742/1847) adolescents intended to accept the third vaccine dose, and 5.7% (105/1847) did not. The results indicated that the acceptance willingness was associated with age (15-17 y), region (Anhui province), district (rural), and educational level (senior high school). Participants who had been quarantined or affected by COVID-19 had more intention to get vaccinated (P < 0.05). In addition to these differences, the confidence for the vaccine safety and effectiveness, and parents’ opinions did affect adolescents’ view on vaccination (P < 0.05). The detailed comparisons of the 2 groups are summarized in Table 1.
*P < 0.05.
Factors Associated With the Third Dose of the COVID-19 Vaccine Acceptance
Multivariate logistic regression for willingness to take the third dose of the COVID-19 vaccine is shown in Table 2. Age between 15 and 17 y, no worry about vaccine safety, confidence for vaccine effectiveness, and supporting opinion from parents were independently associated with acceptance of the third dose (P < 0.05).
*P < 0.05.
Discussion
This study was conducted to investigate the willingness of adolescents at the age of 12-17 y to take the third dose of the COVID-19 vaccine. This study indicated that 94.3% (1742/1847) of participants would like to accept the third dose in the future. The main influencing factors of adolescents’ willingness to accept the third dose were age, concerns about vaccine safety and effectiveness, and parents’ opinions.
Hesitancy to receive vaccination against COVID-19 has been widely reported. Reference Alibrahim and Awad6 The main reasons for the third vaccine dose hesitancy in adolescents found in the present study were concerns about the safety and effectiveness of vaccines, which is consistent with that in other reports. Reference Montalti, Rallo and Guaraldi7,Reference Choi, Jo and Jo8 Hence, the government should focus on the public awareness of the safety and effectiveness of COVID-19 vaccines.
The results found significant associations between parents’ attitudes and COVID-19 vaccine acceptance willingness of the third dose in adolescents, which is in accordance with the previous study that focused on parents’ willingness to accept the COVID-19 vaccine for their children. Reference Catma and Reindl9 This may be due to the fact that adolescents are minors and their behavior is influenced by parents. The results also indicated that vaccinated parents were more supportive of their children getting the third vaccine dose than unvaccinated parents. Recent research reported that adolescents have the capacity to understand benefit and safety concerns about the COVID-19 vaccination, and suggested COVID-19 vaccination of minors without parental consent. Reference Morgan, Schwartz and Sisti10 In the future, public health agencies should stress the safety and effectiveness of vaccines to dismiss the parents’ concerns and improve parents’ own vaccine acceptance rate, which will promote adolescents to get the third dose.
Supplementary material
To view supplementary material for this article, please visit https://doi.org/10.1017/dmp.2022.181.
Author contributions
T.L.: conceptualization, data curation, writing the draft, and statistical analysis. R.Q., Y-H.Z., Y.L., and S-Y.W.: data curation, analysis of data, and review of the draft. B.C. and B.X.: conceptualization and critical revision of the draft.
Funding statement
This research was funded by Jiangsu Innovative and Enterpreneurial Talent Programme (Grant Number: JSSCBS20211510), and funded by Natural Science Foundation of Jiangsu Province (Grant Number: BK20190357).
Conflicts of interest
The authors report no conflict of interest.